Meristem Family Wealth, LLC Vertex Pharmaceuticals Inc Transaction History

Meristem Family Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $345,299 - $385,273	-1,261 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$221.42 - $260.97 $1,771 - $2,087	-8 Reduced 0.63%	1,261 $329,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $46,980 - $52,574	259 Added 25.64%	1,269 $230,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $2,996 - $3,717	-15 Reduced 1.46%	1,010 $240,000
Q4 2019 Jan 31, 2020	BUY	$166.71 - $223.91 $170,877 - $229,507	1,025 New	1,025 $224,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.